425: Kimberly-Clark Supplements Kenvue Merger Proxy Amid Lawsuits

Kimberly-Clark Corporation has filed supplemental disclosures for its Kenvue merger proxy statement to address multiple stockholder lawsuits alleging material omissions and misstatements.

Summary

• Kimberly-Clark Corporation (K-C) filed a Form 8-K to supplement its definitive joint proxy statement/prospectus related to the proposed merger with Kenvue Inc.
• The supplement addresses several stockholder lawsuits filed against Kenvue, its board, and K-C, alleging material omissions and misstatements in prior proxy filings and breaches of fiduciary duties.
• The lawsuits generally seek to enjoin the stockholder votes or the mergers until corrective disclosures are made, among other remedies.
• K-C's board unanimously continues to recommend that K-C stockholders vote FOR the K-C issuance proposal and FOR the K-C adjournment proposal.
• Supplemental disclosures include details on the formation of Kenvue's strategic review committee, the terms of the non-disclosure agreement between Kenvue and K-C, and the engagement of K-C's independent legal counsel.
• Financial analyses from J.P. Morgan, Centerview Partners, and Goldman Sachs, including selected public comparable companies analysis and discounted cash flow analysis, were updated with additional details.
• Unaudited prospective financial information for K-C and Kenvue on a standalone basis, as well as K-C management adjusted Kenvue projections and Kenvue management adjusted K-C projections, for fiscal years 2025-2030 were provided or updated.

Sentiment

Score: 5

Explanation: The filing addresses significant legal challenges (multiple lawsuits) which are negative, but the company is taking proactive steps to mitigate these risks and proceed with the merger, which is a neutral to slightly positive action in the face of adversity. The core merger itself is not being questioned in this filing, only the disclosures around it.

Positives

• K-C's board unanimously recommends stockholders vote FOR the merger-related proposals, indicating continued commitment to the transaction.
• The company is proactively providing supplemental disclosures to mitigate litigation risks and avoid delays in the merger process.
• The non-disclosure agreement between Kenvue and K-C did not contain a "don't ask, don't waive" provision, allowing for confidential proposals.
• K-C engaged independent legal counsel (Gibson Dunn & Crutcher LLP) to assist with due diligence on Kenvue product liability matters, demonstrating thoroughness.

Negatives

• Multiple stockholder lawsuits have been filed against Kenvue, its board, and K-C, alleging material omissions and breaches of fiduciary duties related to the merger.
• The lawsuits seek to enjoin the stockholder vote or the mergers, which could delay or prevent the transaction.
• The company is incurring expenses and distraction defending these actions.
• The need for supplemental disclosures indicates potential deficiencies in the original proxy statements, even if not legally admitted.

Risks

• Risk of termination of the Merger Agreement.
• Risk that conditions to the completion of the proposed transaction (including stockholder and regulatory approvals) are not satisfied in a timely manner or at all.
• Possibility that competing offers or transaction proposals may be made.
• Risks arising from the integration of the K-C and Kenvue businesses.
• Uncertainty of rating agency actions.
• Risk that anticipated benefits and synergies of the proposed transaction may not be realized when expected or at all.
• Risk of unexpected costs or expenses resulting from the proposed transaction.
• Risk of litigation related to the proposed transaction, including resulting expense or delay.
• Risks related to disruption to ongoing business operations and diversion of management's time as a result of the proposed transaction.
• Risk that the proposed transaction may have an adverse effect on the ability of K-C and Kenvue to retain key personnel, customers, and suppliers.
• Risk that the credit ratings of the combined company decline following the proposed transaction.
• Risk that the announcement or consummation of the proposed transaction has a negative effect on the market price of the capital stock of K-C and Kenvue or on K-C's and Kenvue's operating results.
• Risk of product liability litigation or government or regulatory action, including related to product liability claims.
• Risk of product efficacy or safety concerns resulting in product recalls or regulatory action.
• Risks relating to inflation and other economic factors, such as interest rate and currency exchange rate fluctuations.
• Government trade or similar regulatory actions (e.g., tariffs, sanctions) affecting supply chain, commodity costs, and consumer spending.
• Natural disasters, acts of war, terrorism, catastrophes, pandemics, epidemics, or other disease outbreaks.
• Prices and availability of raw materials, manufacturing difficulties or delays, or supply chain disruptions.
• Disruptions in the capital and credit markets.
• Counterparty defaults (customers, suppliers, financial institutions).
• Impairment of goodwill and intangible assets.
• Changes in customer preferences, severe weather conditions, regional instabilities and hostilities.
• Potential competitive pressures on selling prices for K-C and Kenvue products.
• Energy costs, general economic and political conditions globally.
• Ability to maintain key customer relationships, competition (technological advances, new products, intellectual property).
• Challenges inherent in new product research and development, uncertainty of commercial success for new and existing products and digital capabilities.
• Challenges to intellectual property protections, including counterfeiting.
• Ability of K-C and Kenvue to successfully execute business development strategy and other strategic plans.
• Changes to applicable laws and regulations and other requirements imposed by stakeholders.
• Changes in behavior and spending patterns of consumers.

Future Outlook

The filing provides unaudited prospective financial information for K-C and Kenvue on a standalone basis and adjusted projections for the combined entity through fiscal year 2030, indicating expected revenue, Adjusted EBITDA, and Unlevered Free Cash Flow growth. These projections assume the consummation of K-C's International Family Care and Professional segment transaction. The company anticipates realizing cost and growth synergies following the completion of the mergers.

Management Comments

• The K-C board continues to unanimously recommend that K-C stockholders vote FOR the K-C issuance proposal and FOR the K-C adjournment proposal.
• Nothing in the supplemental disclosures set forth below should be deemed an admission of the legal necessity or materiality under applicable laws of any of the disclosures set forth herein.
• The committee was formed for convenience, not on the basis of any conflict of interest, to facilitate the Kenvue board's review of potential strategic alternatives.

Industry Context

The proposed merger between Kimberly-Clark and Kenvue represents a significant consolidation within the consumer staples and personal care sectors. The detailed financial projections and valuation analyses provided by financial advisors reflect standard industry practices for evaluating large-scale M&A transactions. The litigation surrounding the proxy disclosures highlights the intense scrutiny and regulatory compliance requirements prevalent in the industry for such major corporate actions. The focus on synergies and combined company projections suggests a strategic move to enhance market position and operational efficiency in a competitive global market.

Comparison to Industry Standards

• Centerview's Selected Public Comparable Companies Analysis for Kenvue included Church & Dwight Co., Inc. (15.5x EV/2026 EBITDA), Colgate-Palmolive Company (13.5x), Haleon plc (13.6x), Reckitt Benckiser Group PLC (12.6x), The Clorox Company (12.3x), The Procter & Gamble Company (15.8x), and Unilever PLC (14.0x), with a median of 13.6x. Kenvue's implied EV/2026 EBITDA was 9.9x, which is below the median of its comparable companies.
• K-C's implied EV/2026 EBITDA was 11.2x, also below the median of the comparable companies used for Kenvue, suggesting a potentially lower valuation multiple compared to some industry peers.
• The implied exchange ratio range of 0.07099x to 0.18584x (adjusted for cash consideration) derived from analyst price targets was compared to the merger agreement's exchange ratio of 0.14625x, indicating the merger ratio falls within the broader analyst-derived range.

Corporate Governance

Legal Proceedings

• Wisconsin Stockholder Litigation (Steinbrecher v. Kenvue Inc. et al., Case No. 25-cv-1923, filed December 8, 2025) against Kenvue and its board, alleging omissions in the preliminary joint proxy statement/prospectus and violations of Section 14(a) and 20(a) of the Exchange Act and Rule 14a-9.
• New Jersey Stockholder Litigation (Bass v. Allison, Jr., et al., UNNC000001-26, filed January 1, 2026) against Kenvue, its board, and K-C, alleging omissions in the Joint Proxy Statement/Prospectus and violations of the New Jersey Uniform Securities Law, negligent misrepresentation and concealment, and negligence under New Jersey common law.
• Two New York Stockholder Litigations (Jones v. Kenvue Inc. et al., Index No. 650124/2026, filed January 7, 2026; Kent v. Kenvue Inc. et al., Index No. 650178/2026, filed January 8, 2026) against Kenvue and its board, alleging omissions in the Joint Proxy Statement/Prospectus and asserting claims for negligent misrepresentation and concealment and negligence under New York law.
• The Kenvue Complaints generally seek to enjoin the Kenvue stockholder vote or the Mergers until corrective disclosures are made, and attorneys' fees and other litigation costs.
• Demand letters received by Kenvue from purported stockholders alleging material omissions or misstatements and demanding corrective disclosures.
• Delaware Stockholder Litigation (Reese v. Burwell, et al., Case No. 2025-1493, filed December 29, 2025) against K-C's board (with K-C as nominal defendant), alleging breach of fiduciary duties by failing to disclose all material information necessary for K-C stockholders to make an informed decision on the Mergers.
• The K-C Complaint seeks to enjoin K-C's stockholder meeting, find defendants liable for breaching fiduciary duties, certify a proposed class, and award attorneys' fees and litigation costs.
• Demand letters received by K-C from purported stockholders alleging material omissions or misstatements and demanding corrective disclosures.

Related Party Transactions

• J.P. Morgan and its affiliates have had commercial and investment-banking relationships with both K-C and Kenvue, receiving customary compensation. J.P. Morgan acted as joint lead arranger and joint lead bookrunner on a credit facility for K-C in May 2025. J.P. Morgan acted as joint lead bookrunner on an equity offering for Kenvue in May 2024 and passive bookrunner on a debt offering in February 2025, and is a lender under Kenvue's outstanding credit facilities. Aggregate fees from Kenvue were approximately $24.0 million and from K-C were approximately $11.0 million over the two years preceding J.P. Morgan's opinion. J.P. Morgan anticipates providing financing to K-C for the merger, with expected fees of approximately $23.4 million.
• Kirkland & Ellis LLP (Kirkland) represents Kenvue and certain former affiliates on various product liability litigation, while a separate, walled-off team at Kirkland was disclosed to K-C's board and management. Kenvue accounted for less than 1.0% of Kirkland's aggregate revenue in 2025.

Stakeholder Impact

• Shareholders (Kenvue & K-C): Directly impacted by the merger terms, the outcome of the stockholder votes, and the potential for delays or termination due to litigation. The supplemental disclosures aim to provide more complete information for their voting decisions.
• Employees: Potential impact from business integration, synergies, and changes in the combined company structure.
• Customers & Suppliers: Potential impact from changes in product offerings, supply chain, and business relationships post-merger.
• Creditors: Impacted by the financing arrangements for the merger and the combined company's debt structure and credit ratings.

Next Steps

• Kenvue stockholders to hold a special meeting on January 29, 2026, to vote on matters necessary to complete the Mergers.
• K-C stockholders to hold a special meeting on January 29, 2026, to vote on matters necessary to complete the Mergers.
• Potential for additional similar complaints or demand letters to be filed or received.

Key Dates

Recommendation

The filing primarily addresses legal challenges to a previously announced merger, providing supplemental disclosures to mitigate risks. While the company is moving forward and the board unanimously recommends the merger, the existence of multiple lawsuits seeking to enjoin the transaction introduces uncertainty. Investors should hold to monitor the outcome of the stockholder votes and the resolution of the legal proceedings, as these factors will significantly influence the merger's completion and the stock's future performance. The financial projections and valuations are part of the merger process, not new operational results.

Keywords

Kimberly-Clark, Kenvue, Merger Agreement, SEC Filing, Form 8-K, Proxy Statement, Stockholder Litigation, Corporate Governance, Financial Analysis, Adjusted EBITDA, Unlevered Free Cash Flow, Consumer Staples, Acquisition, Risk Factors, Shareholder Vote